Central Garden & Pet Company has announced that it has acquired certain intellectual property assets from Shirlo, Inc. including the company's exclusive marketing rights to "Etofenprox", a leading edge technology insect adulticide approved for on-animal use, for approximately $10 million. "This acquisition is an important step in our strategy to develop new, high-margin products for both professional and consumer lawn & garden and pet insect control marketplaces," noted Glenn Novotny, president and chief executive officer. The acquired assets will be combined with Wellmark International, a wholly owned subsidiary of Central Garden & Pet. Wellmark is the primary producer of "Larvicide (S)-Methoprene", an active ingredient used to control mosquitoes, fleas, ticks, ants and other insects used in leading professional and consumer insect control applications.